New York: The US Food and Drug Administration approved antiviral drug Remdisivir for treating the COVID-19 patients in the country.
The drug reportedly shortened the recovery time by 31 per cent or about four days for the patients admitted to the hospital.
Having manufactured by Gilead Sciences, a California based company, the FDA has allowed the use of the medication only during the pandemic.
Remdesivir, the antiviral drug was found to kill viruses like Ebola, Marburg, MERS and SARS. The medication disables virus RNA (ribonucleic acid) replication (through RNA, coronavirus replicates itself)
However, the drug failed the human trial stage for treating the Ebola virus in 2018-19.
Chandigarh: Odisha rode on a goal each by Anil Toppo and Chandra Mohan Purty to…
New Delhi: King Charles III bestowed his daughter-in-law Kate Middleton with The Royal Companion of…
Hinjli: While formally kicking off the poll campaign from his home constituency Hinjili in Ganjam…
New Delhi: Ravi Kana, Greater Noida's biggest scrap mafia and steel smuggler, and his girlfriend…
Bhubaneswar: The Odisha Joint Entrance Examination Board (OJEEB) on Wednesday released the course wise and shift…
Cuttack: Surendra Bhave, the new head coach of Odisha senior men’s cricket team, would focus…
New Delhi: A day after the Supreme Court, while hearing a contempt case, asked them…
Bhubaneswar: Heatwave may continue to scorch 10 districts of Odisha during the next 24 hours,…